Ulipristal Acetate

CAS 126784-99-4 5 current records 1 historicalSmall Molecule

Who holds supplier records for Ulipristal Acetate? 5 organisations hold a current record for Ulipristal Acetate: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: Italy (2), Spain (1), Taiwan (1) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Ulipristal Acetate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/ulipristal-acetate

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ulipristal Acetate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • CURIA SPAIN SAU
    Active DMF 21527 · latest filing Apr 2008
    Spain Company GMP cert on record
  • Formosa Laboratories, Inc.
    Active DMF 25701 · latest filing Jan 2012
    Taiwan Company GMP cert on record
  • INDUSTRIALE CHIMICA SRL
    Active DMF 32954 · latest filing Jul 2018
    Italy Company GMP cert on record
  • NEWCHEM SPA
    Active DMF 32234 · latest filing Nov 2017
    Italy Company GMP cert on record
  • TAPI NL BV
    Active DMF 27945 · latest filing Apr 2014
    Netherlands
Need Ulipristal Acetate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Ulipristal Acetate are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Ulipristal Acetate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL260538).

Chemical identity

IUPAC name
[(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
Canonical SMILES
CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C
InChIKey
OOLLAFOLCSJHRE-ZHAKMVSLSA-N
Synonyms
CDB-2914, Ella, Ellaone, Esmya, PGL-4001, RTI-3021-012, Ulipristal acet, Ulipristal acetate, Ulipristal acetate gedeon richter, VA-2914, VA2914, CHEBI:71025

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Progesterone Agonist/Antagonist
Mechanism of action
Selective Progesterone Receptor Modulators

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ulipristal Acetate?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Ulipristal Acetate: CURIA SPAIN SAU (Spain), Formosa Laboratories, Inc. (Taiwan), INDUSTRIALE CHIMICA SRL (Italy), NEWCHEM SPA (Italy) and TAPI NL BV (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ulipristal Acetate Drug Master Files are active?

CURIA SPAIN SAU (DMF 21527), Formosa Laboratories, Inc. (DMF 25701), INDUSTRIALE CHIMICA SRL (DMF 32954), NEWCHEM SPA (DMF 32234) and TAPI NL BV (DMF 27945). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ulipristal Acetate records mean?

1 organisation has only inactive Type II DMFs for Ulipristal Acetate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Ulipristal Acetate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ulipristal Acetate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.